SIM
PETS icon

Studio Investment Management’s PetMed Express PETS Stock Holding History

Studio Investment Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-215
Closed -$1.04K – 341
2024
Q4 		$1.04K Buy
+215
New +$1.01K ﹤0.01% 291

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Studio Investment Management's PETS Position: Q1 2025 in Review

Studio Investment Management sold out of PetMed Express (PETS) in Q1 2025, closing a stake of 215 shares — an estimated $1.04K sold.

Studio Investment Management first reported a position in PETS in Q4 2024 and held it in 1 quarter. The position peaked at $1.04K in Q4 2024. 72 funds tracked by Wall St. Rank hold PETS as of Q1 2025.

  • Studio Investment Management reported no remaining PetMed Express position as of Q1 2025 after selling out during the quarter.
  • Studio Investment Management sold 215 PetMed Express shares in Q1 2025, an estimated $1.04K.
  • Studio Investment Management first reported a position in PetMed Express in Q4 2024 and held it in 1 quarter.
  • Studio Investment Management's PetMed Express position peaked at $1.04K in Q4 2024.
  • 72 funds tracked by Wall St. Rank held PetMed Express as of Q1 2025.

Based on Studio Investment Management's 13F filing for Q1 2025, filed 14 May 2025.